KLRK1 and neoplasm: (1) Radiotherapy sensitization combination: DNA damage induced by radiotherapy promotes tumor cells to express NKG2D ligands [60, 61], which subsequently bind to NKG2D receptors on CAR-NK cells and potentiate cytotoxicity through activation of the PI3K–AKT pathway.